Why the study?
Astrovirus VA1 is associated with neurological diseases and can be used as a model system, requiring assays to quantify its replication and propagation.
Provides fundamental assays to quantify replication and propagation of Astrovirus VA1 in cell culture, enabling its use as a model system for neurological diseases.
Cell culture propagation of VA1 enables neurological pathogenesis studies; leaves open any clinical translation or management implications.
Astrovirus VA1/HMO‐C (VA1) is the representative genotype of mamastrovirus 9, a species of the single‐stranded, positive‐sense RNA viral family, Astroviridae . Astroviruses have been traditionally considered pathogens of the gastrointestinal tract but they have been recently associated with neurological diseases in humans, cattle, mink, sheep, and pigs. VA1 is the astrovirus genotype most commonly identified from human cases of meningoencephalitis and has been recently propagated in cell culture. VA1 can now be used as a model system to study pathogenesis of the neurological diseases associated with astrovirus infection. In this article, we describe two fundamental assays to quantify replication and propagation of VA1, a quantitative reverse transcription‐PCR (qRT‐PCR) to measure viral RNA and a 50% tissue culture infectious dose (TCID 50 ) assay to measure infectious viral particles.
No takes yet. Share an insight, caveat, or question.
Janowski et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: